Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
C5 Acquisition Corporation Completes $287.5 Million Initial Public Offering
-
Cantor Fitzgerald Assumes Aspira Women’s Health (AWH) at Overweight
-
Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List
-
10X Capital Venture Acquisition Corp. III (VCXB.U) Prices 26.1M Unit IPO at $10/unit
-
Analysis-Buy the bounce? Investors watch valuations, technical levels to decide
-
10X Capital Venture Acquisition Corp. III Announces Pricing of Upsized $261 Million Initial Public Offering
-
10X Capital Venture Acquisition Corp. III Announces Pricing of Upsized $261 Million Initial Public Offering
-
OrganiGram Holdings Inc (OGI:CN) (OGI) PT Lowered to Cdn$5.30 at Cantor Fitzgerald
-
Tilray (TLRY) PT Lowered to $6.90 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Bionomics Ltd. (BNOX) at Overweight
-
Cantor Fitzgerald Starts Contango Ore (CTGO) at Overweight
-
IPO for SPAC C5 Acquisition Corp (CXAC) Opens at $10.04
-
Cantor Fitzgerald and Capital Innovations Announce Plans to Launch Sustainable Infrastructure Fund
-
C5 Acquisition Corporation Announces Pricing of $250 Million Initial Public Offering
-
Form N-2 CANTOR FITZGERALD SUSTAI
-
Tilray (TLRY) PT Lowered to $7.40 at Cantor Fitzgerald Ahead of Results
-
Aligos Therapeutics Inc. (ALGS) PT Lowered to $17 at Cantor Fitzgerald After Development Halted on ALG-010133
-
Form N-8A CANTOR FITZGERALD SUSTAI
-
Digital Prime Technologies taps industry vet as COO
-
Form 8-K Cantor Fitzgerald Income For: Jan 01
-
Aytu BioScience's (AYTU) Experienced CFO Hire is a Positive For the Company - Cantor Fitzgerald
-
Biohaven Pharmaceutical Holding (BHVN) Likely to Pre-Release NURTEC-OTD Sales - Cantor Fitzgerald
-
Curaleaf (CURLF) PT Lowered to $16.50 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Riot Blockchain (RIOT) at Overweight
-
Blockchain Coinvestors Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 31, 2021
-
Innovative International Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants
-
Semper Paratus Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants
-
Alnylam Pharma (ALNY), Horizon Therapeutics (HZNP) and Mirati Therapeutics (MRTX) Are 2022 Top M&A Targets - Cantor Fitzgerald
-
'Best-Case Exit Strategy': Biogen (BIIB) Stock Falls as Takeover Rumor Denied, But Analysts Bullish on Takeover Prospect
-
Pre-Open Stock Movers 12/29: (TSP) (DNAY) (ORTX) Higher; (MFIN) (FCEL) (RIVN) Lower (more...)
-
Cantor Fitzgerald Assumes Orchard Therapeutics (ORTX) at Overweight, $9 PT
-
Cantor Initiates Brooklyn ImmunoTherapeutics Inc (BTX) at Overweight
-
Satellogic Announces Development of High-Throughput Manufacturing Plant in the Netherlands
-
VYNE Therapeutics (VYNE) and Ardelyx (ARDX) Top Cantor Fitzgerald's Most Shorted Biotech List
-
Form SC 13G EVe Mobility Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Intelligent Medicine Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 27, 2021
-
U.S. authorizes Merck pill as second at-home COVID-19 treatment
-
Legends of Bezogia Announces Cryptocurrency Key Sponsorship of Dubai Globe Soccer Awards
-
US Authorizes Pfizer's (PFE) Oral COVID-19 Treatment, At-home Use Pill is a 'Game-Changer' Says Analyst
-
Horizonte Minerals PLC Announces Completion of Fundraise
-
Satellogic Announces Upcoming Appointment of Six New Board Members
-
Jaguar Health's (JAGX) Recent Approval Underscores that Portfolio and Execution are Underappreciated - Cantor Fitzgerald
-
Form 4 CF Acquisition Corp. For: Dec 20 Filed by: CANTOR FITZGERALD, L. P.
-
Aridis' (ARDS) Omicron Data is Positive, Reiterates Belief that Pipeline is Undervalued - Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Arena Pharma (ARNA) to Neutral
-
CF Acquisition Corp. VII Announces Closing of $182.5 Million Initial Public Offering
-
Intra-Cellular Therapies (ITCI) PT Raised to $62 at Cantor Fitzgerald on FDA Approval
-
Mondee To Go Public Through Business Combination with ITHAX Acquisition Corporation (ITHX)
-
Mondee, the Technology-First, Fast Growing Travel Market Disruptor, To Go Public Through Business Combination with ITHAX Acquisition Corporation
-
Mondee, the Technology-First, Fast Growing Travel Market Disruptor, To Go Public Through Business Combination with ITHAX Acquisition Corporation

